A Randomized, Multi-Cohort Phase II Trial of Temozolomide and Atezolizumab
as Second Line Treatment for Small Cell Lung Cancer

Status: Open to Accrual

Learn more

• https://clinicaltrials.gov/study/NCT04919382
• See study locations on Big Ten CRC website

Study Contact: studies@hoosiercancer.org; 317-921-2050